FDA panel narrowly backs Merck's at-home COVID-19 pill
FDA panel narrowly backs Merck's at-home COVID-19 pill
December 01, 2021
A panel of expert advisers to the U.S. Food and Drug Administration on Tuesday narrowly voted to recommend the agency authorize Merck & Co's antiviral pill to treat COVID-19.
Post A Comment:
0 comments:
Leave a comment. Thanks!